Acute Hepatic Porphyria (AHP)

Sponsored diagnostic testing programs for Acute Hepatic Porphyria (AHP)

Acute hepatic porphyria (AHP) is a group of rare inherited disorders caused by enzyme defects in the heme pathway, leading to buildup of neurotoxic intermediates. Attacks may include severe abdominal pain and neurologic or autonomic symptoms. Because signs can mimic other conditions, genetic testing helps confirm the diagnosis.

1 program found for Acute Hepatic Porphyria (AHP)

Featured Programs

1 program
Acute Hepatic Porphyria (AHP)
Alnylam Act
Sponsored by
Alnylam Pharmaceuticals

Alnylam Act® Acute Hepatic Porphyria

The Alnylam Act® program supports eligible patients in the U.S. and Canada with no-cost access to genetic testing and counseling for acute hepatic porphyria (AHP), facilitating diagnostic clarity in this rare metabolic condition. Services are delivered by independent third-party providers and governed under a strict policy of de-identified data sharing for research purposes.

Cardiology
ViewOrder
Performing labPrevention Genetics
Featured